How to buy CareDx (CDNA) stock

CareDx, Inc is a diagnostics & research business based in the US. CareDx shares (CDNA) are listed on the NASDAQ and all prices are listed in US Dollars. CareDx employs 456 staff and has a trailing 12-month revenue of around 0.00.

CareDx stock price (NASDAQ: CDNA)

Use our graph to track the performance of CDNA stocks over time.

CareDx shares at a glance

• Key figures

Information last updated 2021-07-22.

Latest market close	$80.40
52-week range	$29.86 - $99.83
50-day moving average	$87.85
200-day moving average	$79.18
Wall St. target price	$100.33
PE ratio	N/A
Dividend yield	$1.576 (1.86%)
Earnings per share (TTM)	$-0.97

Buy CareDx shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy CareDx stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of CareDx, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

CareDx price performance over time

Historical closes compared with the close of $80.4 from 2021-05-28

1 week (2021-07-17)	N/A
1 month (2021-06-28)	-15.47%
3 months (2021-04-28)	-0.05%
6 months (2021-01-24)	N/A

1 year (2020-07-24)	N/A
2 years (2019-07-24)	N/A
3 years (2018-07-24)	N/A
5 years (2016-07-24)	N/A

CareDx financials

Revenue TTM	$221.2 million
Gross profit TTM	$80.1 million
Return on assets TTM	-3.16%
Return on equity TTM	-4.74%
Profit margin	-6.14%
Book value	$9.08
Market capitalisation	$4.4 billion

TTM: trailing 12 months

Shorting CareDx shares

There are currently 3.9 million CareDx shares held short by investors – that's known as CareDx's "short interest". This figure is 4.1% down from 4.1 million last month.

There are a few different ways that this level of interest in shorting CareDx shares can be evaluated.

CareDx's "short interest ratio" (SIR)

CareDx's "short interest ratio" (SIR) is the quantity of CareDx shares currently shorted divided by the average quantity of CareDx shares traded daily (recently around 770884.47937132). CareDx's SIR currently stands at 5.09. In other words for every 100,000 CareDx shares traded daily on the market, roughly 5090 shares are currently held short.

However CareDx's short interest can also be evaluated against the total number of CareDx shares, or, against the total number of tradable CareDx shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CareDx's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 CareDx shares in existence, roughly 80 shares are currently held short) or 0.0764% of the tradable shares (for every 100,000 tradable CareDx shares, roughly 76 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against CareDx.

Find out more about how you can short CareDx stock.

CareDx share dividends

We're not expecting CareDx to pay a dividend over the next 12 months.

CareDx share price volatility

Over the last 12 months, CareDx's shares have ranged in value from as little as $29.86 up to $99.83. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while CareDx's is 0.6464. This would suggest that CareDx's shares are less volatile than average (for this exchange).

CareDx overview

CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It offers AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; and AlloSure Heart, a dd-cfDNA test to identify underlying cell injury leading to organ rejection. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; Olerup SBT, a product range for sequence-based typing of HLA alleles; QTYPE that enables precision in HLA typing at a low to intermediate resolution for samples that uses real-time polymerase chain reaction methodology; and TruSight HLA, a next generation sequencing (NGS) based high resolution typing solution. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Ottr, a transplant patient tracking software; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors. CareDx, Inc.

Frequently asked questions

What percentage of CareDx is owned by insiders or institutions?
Currently 1.991% of CareDx shares are held by insiders and 102.969% by institutions. How many people work for CareDx?
Latest data suggests 456 work at CareDx. When does the fiscal year end for CareDx?
CareDx's fiscal year ends in December. Where is CareDx based?
CareDx's address is: 1 Tower Place, South San Francisco, CA, United States, 94080 What is CareDx's ISIN number?
CareDx's international securities identification number is: US14167L1035 What is CareDx's CUSIP number?
CareDx's Committee on Uniform Securities Identification Procedures number is: 14167L103